Cargando…
RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis
BACKGROUND: This meta-analysis evaluated the clinicopathologic and prognostic significance of RASSF1A promoter methylation in renal cell carcinoma (RCC). MATERIALS AND METHODS: The ORs or HRs and their 95% CIs were calculated. Trial sequential analysis was conducted. RESULTS: Twenty-two articles tha...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304251/ https://www.ncbi.nlm.nih.gov/pubmed/30588036 http://dx.doi.org/10.2147/OTT.S183142 |